The Business Research Company’s Brain Tumor Drugs Global Market Report 2021 : COVID-19 Impact And Recovery
LONDON, GREATER LONDON , UK, October 28, 2021 /EINPresswire.com/ — According to the new market research report ‘Brain Tumor Drugs Global Market Report 2021: COVID-19 Impact And Recovery’ published by The Business Research Company, the brain tumor drugs market is expected to grow from $1.89 billion in 2020 to $2.01 billion in 2021 at a compound annual growth rate (CAGR) of 6.3%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $2.89 billion in 2025 at a CAGR of 9.5%. The major driving factor responsible for the growth of the brain tumor market is the increasing prevalence of neurological disorders worldwide.
Request For A Sample For The Global Brain Tumor Drugs Market Report:
The brain tumor drugs market consists of sales of drugs which are used to cure a mass growth of abnormal cells in the human brain. These drugs are either used alone or in combinations, depending on the type, size and locations of the tumor. For example, Afinitor (Everolimus), BiCNU (Carmustine), Everolimus, Carmustine, Temozolomide and Avastin (Bevacizumab) are some of the drugs included in this market.
Trends In The Global Brain Tumor Drugs Market
Companies in the brain tumor market are focusing on the use of nanotechnology for treatment. The nanoparticles are being used to carry drugs in combination, directly to the cancer cells or into the tumor. This technology has also led to a reduction in dosage of the drugs, improved shelf life and reduce toxicity. A few nanodrugs are proving to be useful in overcoming the blood-brain barrier, which was a significant challenge in the treatment of Brain tumors. For instance, Liposomes nanoparticles facilitate easy delivery of drugs to the core cancer cells, these particles if coated with transferrin can even pass through the blood-brain barrier. Companies like GE Healthcare, Sigma-Tau Pharmaceuticals Inc., Johnson & Johnson, Merck & Company Inc., Pfizer, Inc., Celgene Corporation are adopting this technology to improve the available techniques of medication and treatment.
Global Brain Tumor Drugs Market Segments:
The global brain tumor drugs market is further segmented:
By Drugs: Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib
By End User: Hospital Pharmacies, Clinics, Others
By Geography: The global brain tumor drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Brain Tumor Drugs Market At:
Brain Tumor Drugs Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides brain tumor drugs global market overviews, analyzes and forecasts market size and growth for the global brain tumor drugs market, brain tumor drugs global market share, brain tumor drugs global market players, brain tumor drugs global market segments and geographies, brain tumor drugs market’s leading competitors’ revenues, profiles and market shares. The brain tumor drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Read Brain Tumor Drugs Global Market Report 2021 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country, Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Brain Tumor Drugs Market Organizations Covered: Pfizer Inc., Shimadzu Corporation, Toshiba Medical Systems, Merck & Co. Inc., AstraZeneca.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Here is a list of reports from The Business Research Company similar to the Brain Tumor Drugs Global Market Report 2021:
Brain And Neuroimaging Devices Global Market Report 2021 – By Imaging Type (Functional Magnetic Resonance Imaging (FMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG)), By End-User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), By Application (Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders), COVID-19 Growth And Change
Diagnostic Imaging Equipment Global Market Report 2021 – By Type (X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories, Others), By Type Of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), COVID-19 Impact And Recovery
Alpha Mannosidosis Global Market Report 2021 – By Therapy Type (Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT), Gene Therapy), By Indication (Type I, Type II, Type III), By End-User (Hospitals, Specialty Clinics), COVID-19 Growth And Change
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293